© Copyright 2025 American Medical Association. All rights reserved.
A tissue cultured allogeneic dermal substitute is a specialized medical product used to treat wounds or skin defects on various parts of the body, including the face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and multiple digits. This substitute is derived from human fibroblast cells, which are essential components of the skin that help in wound healing and tissue regeneration. The fibroblasts are cultivated from newborn foreskin tissue and are then seeded onto a bioabsorbable mesh scaffold. As these fibroblasts proliferate, they fill the mesh scaffold and secrete important substances such as human dermal collagen, matrix proteins, growth factors, and cytokines. These substances play a crucial role in regulating the immune response and promoting healing. The end product is a metabolically active, living dermal substitute that can effectively cover and support the healing of skin defects. During the procedure, the dermal substitute is carefully removed from its transport container and applied to a prepared wound bed, where it is secured in place using sutures or staples. Following this, a layered dressing is applied to protect the substitute and facilitate healing, which includes a nonadherent layer, a bulky layer of gauze, a compression layer, and an anti-shear layer. This procedure is coded as 15365 for the first 100 square centimeters or less in adults or for 1% of total body surface area in infants and children, while 15366 is used for each additional 100 square centimeters or 1% of total body surface area in infants and children or part thereof.
© Copyright 2025 Coding Ahead. All rights reserved.
The tissue cultured allogeneic dermal substitute is indicated for use in patients with skin defects or wounds located on specific areas of the body. These areas include:
The procedure for applying a tissue cultured allogeneic dermal substitute involves several critical steps to ensure proper placement and healing. First, the wound bed must be adequately prepared, which may include cleaning the area and removing any necrotic tissue to create an optimal environment for the dermal substitute. Once the wound bed is prepared, the tissue cultured allogeneic dermal substitute is carefully removed from its transport container. It is essential to handle the substitute gently to maintain the integrity of the living cells within it. The substitute is then positioned over the prepared wound bed, ensuring that it adequately covers the defect. After placement, the dermal substitute is secured in place using sutures or staples, which help to anchor it and prevent movement during the healing process. Following the securement of the substitute, a layered dressing is applied to protect the area and facilitate healing. This dressing typically consists of a nonadherent layer that prevents sticking to the substitute, a bulky layer of gauze to absorb any exudate, a compression layer to minimize swelling, and an anti-shear layer to reduce friction and movement. This comprehensive approach ensures that the dermal substitute remains in place and promotes optimal healing conditions.
After the application of the tissue cultured allogeneic dermal substitute, post-procedure care is crucial for ensuring successful healing. The layered dressing should remain intact for a specified period, as directed by the healthcare provider, to protect the substitute and the underlying wound. Patients may be advised to monitor the site for any signs of infection, such as increased redness, swelling, or discharge. Follow-up appointments may be scheduled to assess the healing process and determine if any additional interventions are necessary. It is important to follow the healthcare provider's instructions regarding activity restrictions and care of the dressing to promote optimal recovery. The expected recovery time may vary depending on the size and location of the wound, as well as the individual patient's healing response.
Short Descr | APPLY CULT DERM SUB F/N/HF/G | Medium Descr | TISS CLTR ALGC DRM F/S/N/H/F/G/M/D 1ST 100 CM | Long Descr | TISS CLTR ALGC DRM F/S/N/H/F/G/M/D 1ST 100 CM | Status Code | Active Code | Global Days | 090 - Major Surgery | PC/TC Indicator (26, TC) | 0 - Physician Service Code | Multiple Procedures (51) | 2 - Standard payment adjustment rules for multiple procedures apply. | Bilateral Surgery (50) | 0 - 150% payment adjustment for bilateral procedures does NOT apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 1 - Statutory payment restriction for assistants at surgery applies to this procedure... | Co-Surgeons (62) | 0 - Co-surgeons not permitted for this procedure. | Team Surgery (66) | 0 - Team surgeons not permitted for this procedure. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Discontinued Code | Type of Service (TOS) | 2 - Surgery | Berenson-Eggers TOS (BETOS) | none | MUE | Not applicable/unspecified. | CCS Clinical Classification | 172 - Skin graft |
Get instant expert-level medical coding assistance.